Login to Your Account



Financings Roundup


Thursday, September 27, 2012
• Northwest Biotherapeutics Inc., of Bethesda, Md., effected a 1-for-16 reverse split. The split is the first step toward a planned public offering of up to $25 million, and listing on the Nasdaq Capital Market.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription